Cannabidiol for the treatment of cannabis use disorder: Phase IIa double-blind placebo-controlled randomised adaptive Bayesian dose-finding trial
- Submitting institution
-
University of Exeter
- Unit of assessment
- 4 - Psychology, Psychiatry and Neuroscience
- Output identifier
- 6572
- Type
- D - Journal article
- DOI
-
10.1016/S2215-0366(20)30290-X
- Title of journal
- Lancet Psychiatry
- Article number
- -
- First page
- 865
- Volume
- 7(10)
- Issue
- 10
- ISSN
- 2215-0366
- Open access status
- Compliant
- Month of publication
- July
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
15
- Research group(s)
-
C - Clinical
- Citation count
- 10
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- CJAM made a substantial contribution to the conception and design of the study and review of the data and critiqued the output for important intellectual content.
- Non-English
- No
- English abstract
- -
